Published in Br Med J (Clin Res Ed) on February 19, 1983
Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther (2008) 1.09
Still's disease associated with Coxsackie infection and haemophagocytic syndrome. Ann Rheum Dis (1985) 0.91
Virus infection and knee injury. Arch Emerg Med (1987) 0.82
Polymyalgic presentation of enterovirus infection: a cause of diagnostic confusion. Ann Rheum Dis (1996) 0.75
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62
Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA (1976) 1.45
Coxsackie B neutralisation titres in polymyositis/dermatomyositis. Lancet (1977) 1.28
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Cattle movements and bovine tuberculosis in Great Britain. Nature (2005) 4.90
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Systemic lupus erythematosus. Lancet (2001) 4.18
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (1997) 4.14
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996). Pharmacoeconomics (2001) 3.03
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 2.89
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg (1989) 2.84
Activin signalling and response to a morphogen gradient. Nature (1994) 2.70
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol (1989) 2.22
Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis (1973) 2.12
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12
Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease. Stroke (2000) 2.11
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Medical staffing in Ontario neonatal intensive care units. CMAJ (1989) 1.97
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis (1967) 1.89
Pathways of nucleotide biosynthesis in Mycoplasma mycoides subsp. mycoides. J Bacteriol (1977) 1.87
Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
Vocational part-time training: jobs for the girls and boys. Med J Aust (2001) 1.82
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol (1989) 1.77
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76
Central nervous system lupus--diagnosis and treatment. J Rheumatol (1980) 1.75
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis (1989) 1.73
The painful metal-on-metal hip resurfacing. J Bone Joint Surg Br (2009) 1.72
Eomesodermin, a key early gene in Xenopus mesoderm differentiation. Cell (1996) 1.72
A highly conserved nuclear gene for low-level phylogenetics: elongation factor-1 alpha recovers morphology-based tree for heliothine moths. Mol Biol Evol (1995) 1.70
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis (1982) 1.64
Deficiency of factor B of the complement system in sickle cell anaemia. Br Med J (1976) 1.61
Postdischarge geriatric assessment of hospitalized frail elderly patients. Arch Intern Med (1996) 1.61
Enzymes of purine metabolism in Mycoplasma mycoides subsp. mycoides. J Bacteriol (1978) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Hypoadrenalism, Addison's disease and antiphospholipid antibodies. J Rheumatol (1991) 1.60
Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum (1979) 1.57
Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol (1977) 1.57
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56
Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56
Significance of persisting serologic abnormalities in SLE. Arthritis Rheum (1976) 1.56
The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56
Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis (1983) 1.55
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1979) 1.54
Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med (1984) 1.54
Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol (1998) 1.54
Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J (1985) 1.54
Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis (1982) 1.53
The anticardiolipin syndrome. Clin Exp Rheumatol (1986) 1.53
Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost (1997) 1.52
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. BMJ (1989) 1.52
Rheumatoid arthritis and food: a case study. Br Med J (Clin Res Ed) (1981) 1.52
Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med (1984) 1.52